Middle East & Africa l Uterine cancer therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2016 - 2021)

  • ID: 3784667
  • Report
  • Region: Africa, East Africa, Middle East
  • 82 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Ariad Pharmaceuticals
  • Becton Dickinson & co
  • GlaxoSmithKline Plc
  • Merck & Co.
  • Novartis AG
  • MORE
Uterine cancer is a common cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, around 47,130 new cases of endometrial cancer were diagnosed, and 8,010 women died from it in 2012.

The Middle East & Africa uterine cancer market is expected to grow modestly from USD 390 million in 2015, at a CAGR of 2-6%.

The Middle East & Africa Uterine Cancer Therapeutics & Diagnostic Market is segmented based on:

- Type
- Uterine sarcomas
- Endometrial carcinomas (Has various sub-types)
- Treatment
- Surgery
- Chemotherapy
- Immunotherapy
- Radiation therapy
- Follow-up Treatment.

Furthermore, the diagnostics market is segmented under major tests such as:

- Biopsy
- Pelvic Ultrasound
- Hysteroscopy
- Dilation and curettage
- CT Scan

Based on geography it is segmented as:

- Qatar
- Saudi Arabia
- South Africa

Some of the key participants in the industry include Ariad Pharmaceuticals, Inc., Abbott Laboratories, Becton, Dickinson & Co., Merck & Co., Inc., GlaxoSmithKline Plc, Novartis AG, Sanofi, Siemens Healthcare Inc., Roche Ltd etc.

Drivers:

- Upsurge in awareness about uterine diseases
- Available therapies in the market
- Increasing health care expenditure
- Increasing incidences of uterine cancer
- Technological developments & drug innovations with regard to uterine cancer
- Advanced health care services

Restraints:

- Low success rate in clinical trials for cancer drugs
- High cost associated with the treatment
- Adverse side-effects
- High toxicity of drugs

Please note: As this product is updated at the time of order, dispatch will be 72 hours from the date the order and full payment is received
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Ariad Pharmaceuticals
  • Becton Dickinson & co
  • GlaxoSmithKline Plc
  • Merck & Co.
  • Novartis AG
  • MORE
1. Introduction
1.1 Market Definition
1.2 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Drivers
3.1.1 Rise in awareness about Uterine diseases and their available therapies
3.1.2 Increasing health care expenditure
3.1.3 Innovation in drug development, and subsequent technological advancements
3.2 Market Restraints
3.2.1 Low success rate in clinical trails for cancer drugs
3.2.2 High cost associated with the treatment
3.2.3 Adverse side-effects of treatment and high toxicity of drugs
3.3 Market Opportunitites
3.4 Market Threats
4. Porters Five Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market Segmentation
5.1 Middle East & Africa Uterine Cancer Therapeutics & Diagnostic Market, by Cancer Type
5.1.1 Uterine sarcomas
5.1.2 Endometrial carcinomas
5.1.2.1 Adenocarcinoma
5.1.2.2 Carcinosarcoma
5.1.2.3 Squamous cell carcinoma
5.1.2.4 Others
5.2 Middle East & Africa Uterine Cancer Therapeutics Market
5.2.1 Surgery
5.2.2 Immunotherapy
5.2.3 Radiation therapy
5.2.4 Chemotherapy
5.2.5 Follow-up Treatment
5.3 Middle East & Africa Uterine Cancer Diagnostics Market
5.3.1 Biopsy
5.3.2 Pelvic ultrasound.
5.3.3 Hysteroscopy
5.3.4 Dilation and curettage
5.3.5 CT scan
5.4 Middle East & Africa Uterine Cancer Therapeutics & Diagnostics Market, By Region
5.4.1 South Africa
5.4.2 Saudi Arabia
5.4.3 Qatar
6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company Profiles
7.1 Ariad Pharmaceuticals, Inc.
7.2 Abbott Laboratories
7.3 Becton, Dickinson & Co.
7.4 GlaxoSmithKline Plc
7.5 Merck & Co., Inc.
7.6 Novartis AG
7.7 Sanofi
7.8 Siemens Healthcare Inc
7.9 Roche Ltd
8. Appendix
8.1. Abbreviations
8.2. Sources
8.3. Bibliography
8.4. Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Ariad Pharmaceuticals
Abbott Laboratories
Becton Dickinson & co
GlaxoSmithKline Plc
Merck & Co.
Novartis AG
Sanofi
Siemens Healthcare Inc.
Roche Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll